WASHINGTON (dpa-AFX) - Eisai Inc. and Arena Pharmaceuticals, Inc. (ARNA)
today announced the availability of Belviq XR, or lorcaserin Hcl, CIV
extended-release 20 mg tablets, a new once-daily dosing option that may help
some patients achieve and...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.